BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 18605714)

  • 1. Highly specific and broadly potent inhibitors of mammalian secreted phospholipases A2.
    Oslund RC; Cermak N; Gelb MH
    J Med Chem; 2008 Aug; 51(15):4708-14. PubMed ID: 18605714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the complete set of mammalian secreted phospholipases A(2) by indole analogues: a structure-guided study.
    Smart BP; Pan YH; Weeks AK; Bollinger JG; Bahnson BJ; Gelb MH
    Bioorg Med Chem; 2004 Apr; 12(7):1737-49. PubMed ID: 15028265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for functional selectivity and ligand recognition revealed by crystal structures of human secreted phospholipase A
    Hou S; Xu T; Xu J; Qu L; Xu Y; Chen L; Liu J
    Sci Rep; 2017 Sep; 7(1):10815. PubMed ID: 28883454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New quinoxalinone inhibitors targeting secreted phospholipase A2 and α-glucosidase.
    Alasmary FAS; Alnahdi FS; Ben Bacha A; El-Araby AM; Moubayed N; Alafeefy AM; El-Araby ME
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1143-1151. PubMed ID: 28856929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secreted Phospholipases A
    Ivanušec A; Šribar J; Križaj I
    Int J Biol Sci; 2022; 18(2):873-888. PubMed ID: 35002531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Group IID, IIE, IIF and III secreted phospholipase A
    Murakami M; Miki Y; Sato H; Murase R; Taketomi Y; Yamamoto K
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Jun; 1864(6):803-818. PubMed ID: 30905347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of new potent and selective secretory phospholipase A2 inhibitors. Part 5: synthesis and biological activity of 1-alkyl-4-[4,5-dihydro-1,2,4-[4H]-oxadiazol-5-one-3-ylmethylbenz-4'-yl(oyl)] piperazines.
    Boukli L; Touaibia M; Meddad-Belhabich N; Djimdé A; Park CH; Kim JJ; Yoon JH; Lamouri A; Heymans F
    Bioorg Med Chem; 2008 Feb; 16(3):1242-53. PubMed ID: 17993277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of tumor necrosis factor alpha-induced secreted phospholipase A2 (sPLA2)-IIA expression in mesangial cells by an autocrine loop involving sPLA2 and peroxisome proliferator-activated receptor alpha activation.
    Beck S; Lambeau G; Scholz-Pedretti K; Gelb MH; Janssen MJ; Edwards SH; Wilton DC; Pfeilschifter J; Kaszkin M
    J Biol Chem; 2003 Aug; 278(32):29799-812. PubMed ID: 12782627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex vivo effect of varespladib on secretory phospholipase A2 alveolar activity in infants with ARDS.
    De Luca D; Minucci A; Piastra M; Cogo PE; Vendittelli F; Marzano L; Gentile L; Giardina B; Conti G; Capoluongo ED
    PLoS One; 2012; 7(10):e47066. PubMed ID: 23071714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of LY315920/S-5920, [[3-(aminooxoacetyl)-2-ethyl-1- (phenylmethyl)-1H-indol-4-yl]oxy] acetate, a potent and selective secretory phospholipase A2 inhibitor: A new class of anti-inflammatory drugs, SPI.
    Snyder DW; Bach NJ; Dillard RD; Draheim SE; Carlson DG; Fox N; Roehm NW; Armstrong CT; Chang CH; Hartley LW; Johnson LM; Roman CR; Smith AC; Song M; Fleisch JH
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1117-24. PubMed ID: 10027849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular modeling of the additional inhibitor site located in secretory phospholipase A(2).
    Ompraba G; Velmurugan D; Louis PA; Rafi ZA
    J Biomol Struct Dyn; 2010 Feb; 27(4):489-500. PubMed ID: 19916570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of new secretory phospholipase A2-inhibitory indole containing isoxazole derivatives as anti-inflammatory and anticancer agents.
    Pedada SR; Yarla NS; Tambade PJ; Dhananjaya BL; Bishayee A; Arunasree KM; Philip GH; Dharmapuri G; Aliev G; Putta S; Rangaiah G
    Eur J Med Chem; 2016 Apr; 112():289-297. PubMed ID: 26907155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of secreted phospholipases A₂ by 2-oxoamides based on α-amino acids: Synthesis, in vitro evaluation and molecular docking calculations.
    Mouchlis VD; Magrioti V; Barbayianni E; Cermak N; Oslund RC; Mavromoustakos TM; Gelb MH; Kokotos G
    Bioorg Med Chem; 2011 Jan; 19(2):735-43. PubMed ID: 21216150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secretory phospholipases A2 induce beta-glucuronidase release and IL-6 production from human lung macrophages.
    Triggiani M; Granata F; Oriente A; De Marino V; Gentile M; Calabrese C; Palumbo C; Marone G
    J Immunol; 2000 May; 164(9):4908-15. PubMed ID: 10779801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the role of protein disulfide isomerase in the retrograde cell transport of secreted phospholipases A2.
    Oberčkal J; Kovačič L; Šribar J; Leonardi A; Dolinar K; Pucer Janež A; Križaj I
    PLoS One; 2015; 10(3):e0120692. PubMed ID: 25763817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and Functional Aspects of Targeting the Secreted Human Group IIA Phospholipase A
    Kim RR; Chen Z; Mann TJ; Bastard K; F Scott K; Church WB
    Molecules; 2020 Sep; 25(19):. PubMed ID: 32998383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of N-[2-(2,4-Difluorophenoxy)trifluoromethyl-3-pyridyl]sulfonamides and their inhibitory activities against secretory phospholipase A₂.
    Nakayama H; Ishihara K; Akiba S; Uenishi J
    Chem Pharm Bull (Tokyo); 2011; 59(8):1069-72. PubMed ID: 21804258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secreted phospholipases A2 in cancer: diverse mechanisms of action.
    Brglez V; Lambeau G; Petan T
    Biochimie; 2014 Dec; 107 Pt A():114-23. PubMed ID: 25286228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Varespladib inhibits secretory phospholipase A2 in bronchoalveolar lavage of different types of neonatal lung injury.
    De Luca D; Minucci A; Trias J; Tripodi D; Conti G; Zuppi C; Capoluongo E;
    J Clin Pharmacol; 2012 May; 52(5):729-37. PubMed ID: 21602519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a Novel Heart-Liver Axis: Matrix Metalloproteinase-2 Negatively Regulates Cardiac Secreted Phospholipase A2 to Modulate Lipid Metabolism and Inflammation in the Liver.
    Hernandez-Anzaldo S; Berry E; Brglez V; Leung D; Yun TJ; Lee JS; Filep JG; Kassiri Z; Cheong C; Lambeau G; Lehner R; Fernandez-Patron C
    J Am Heart Assoc; 2015 Nov; 4(11):. PubMed ID: 26567374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.